OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Dulce Brito, Fabiano Castro Albrecht, Diego Pérez de Arenaza, et al.
Global Heart (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Suspicion and referral of patients with transthyretin amyloid cardiomyopathy: Recommendations by a Portuguese multidisciplinary expert panel
Dulce Brito, J R Agostinho, Carlos Aguíar, et al.
Revista Portuguesa de Cardiologia (2025) Vol. 44, pp. 59-68
Open Access | Times Cited: 3

Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy
Daniel P. Judge, Kevin Alexander, Francesco Cappelli, et al.
Journal of the American College of Cardiology (2025) Vol. 85, Iss. 10, pp. 1003-1014
Open Access | Times Cited: 3

Outpatient Worsening Heart Failure in Patients with Transthyretin Amyloidosis with Cardiomyopathy in the HELIOS-B Trial
Alberico Del Torto, Matthew J. Maurer, Julian D. Gillmore, et al.
Journal of the American College of Cardiology (2024)
Open Access | Times Cited: 4

2025 Update Consensus of
Shan-Ying Wang, Yih-Hwen Huang, Yi‐Chieh Chen, et al.
PubMed (2025) Vol. 41, Iss. 1, pp. 55-71
Closed Access

Análisis de las características clínicas y pronóstico de los pacientes con amiloidosis cardiaca ingresados en los hospitales españoles (2016-2021)
Alberto Esteban‐Fernández, Manuel Anguita-Sá́nchez, Nicolás Rosillo, et al.
Revista Clínica Española (2025)
Closed Access

Emerging, novel gene-modulating therapies for transthyretin amyloid cardiomyopathy
Song Peng Ang, Jia Ee Chia, Debabrata Mukherjee
Heart Failure Reviews (2025)
Open Access

Transthyretin Amyloid Cardiomyopathy as the Cause of Aortic Stenosis
M. V. Ezhikova, S. N. Nasonova, И. В. Жиров, et al.
Kardiologiia (2025) Vol. 65, Iss. 2, pp. 69-76
Closed Access

A Case of Transthyretin Amyloid (ATTR)
庆 雷
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 573-580
Closed Access

Transthyretin Amyloid Cardiomyopathy: Current Diagnostic Approach and Risk Stratification with Multimodality Imaging
Georgios Tziomalos, Thomas Zegkos, Eleftheria Baltagianni, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2014-2014
Open Access

Integrated specialty care for amyloidosis: a scoping review using the Consolidated Framework for Implementation Research
Mary J. O’Sullivan, Wahab Osman, Archanaa Krisnagopal, et al.
BMC Health Services Research (2025) Vol. 25, Iss. 1
Open Access

Incidence and associated factors with atrial fibrillation in patients with transthyretin amyloidosis cardiomyopathy: Insights from the multicenter REACT-SP registry
Cristhian Espinoza Romero, Edileide B. Correia, Alzira De Siqueira Carvalho, et al.
IJC Heart & Vasculature (2025) Vol. 58, pp. 101658-101658
Closed Access

Changing Treatment Landscape in Transthyretin Cardiac Amyloidosis
Marianna Fontana, John L. Berk, Brian Drachman, et al.
Circulation Heart Failure (2025)
Closed Access

Rna-Targeting Therapies For Amyloid Transthyretin Cardiomyopathy: A Systematic Review And Meta-Analysis
João Victor de Oliveira Ramos, João Vítor Andrade Fernandes, Yan Gadelha de Abrantes Formiga, et al.
Current Problems in Cardiology (2025), pp. 103057-103057
Closed Access

Cardiac Amyloid, The Great Imitator
Nick C. Fox, Nick C. Fox, Emily Newman, et al.
JACC Case Reports (2025), pp. 103373-103373
Open Access

Rabdomiólisis relacionada con estatinas en contexto de interacción farmacológica con tafamidis
Pablo Peláez-Ibáñez, Núria Trullén-Malaret, Marta Fanlo-Maresma
Medicina Clínica (2025) Vol. 164, Iss. 12, pp. 106947-106947
Closed Access

Vutrisiran Improves Survival and Reduces Cardiovascular Events in ATTR Amyloid Cardiomyopathy
Ronald Witteles, Pablo García‐Pavía, Thibaud Damy, et al.
Journal of the American College of Cardiology (2025)
Open Access

Hypertrophic Cardiomyopathy
Jason Dungu, Amy Hardy-Wallace, Anthony Dimarco, et al.
Current Heart Failure Reports (2024) Vol. 21, Iss. 4, pp. 428-438
Closed Access | Times Cited: 3

Recent advances in the diagnostic methods and therapeutic strategies of transthyretin cardiac amyloidosis
Christos Kourek, Αlexandros Briasoulis, Dimitrios E. Magouliotis, et al.
World Journal of Cardiology (2024) Vol. 16, Iss. 7, pp. 370-379
Open Access | Times Cited: 2

Cardiac Amyloidosis: State-of-the-Art Review in Molecular Pathology
Cecilia Salzillo, Renato Franco, Andrea Ronchi, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 10, pp. 11519-11536
Open Access | Times Cited: 2

Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fraction
Anouk Achten, Steven A. Muller, Sandra Sanders‐van Wijk, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top